![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/17 | |
A61P 31/10 | |||
C07K 14/47 |
(11) | Number of the document | 2717902 |
(13) | Kind of document | T |
(96) | European patent application number | 12796397.3 |
Date of filing the European patent application | 2012-06-06 | |
(97) | Date of publication of the European application | 2014-04-16 |
(45) | Date of publication and mention of the grant of the patent | 2018-01-24 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2012/041092 |
Date | 2012-06-06 |
(87) | Number | WO 2012/170524 |
Date | 2012-12-13 |
(30) | Number | Date | Country code |
201161493845 P | 2011-06-06 | US |
(72) |
GEORGOPOULOS, Lynne, M., US
ARNOLD, Susan, US
|
(73) |
Phasebio Pharmaceuticals, Inc.,
One Great Valley Parkway Suite 30, Malvern, Pennsylvania 19355,
US
|
(54) | USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION |
USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION |